ArticleMedicine2025
Methicillin-resistant Staphylococcus aureus (MRSA) infection of the temple region of the face: Case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleA carbuncle is a type of superficial soft-tissue infection involving hair follicles, typically starting as a furuncle. Multiple furuncles can coalesce to form a carbuncle. Methicillin-resistant Staphylococcus aureus (MRSA) is a common commensal organism on the skin and is known to cause infections, particularly in hospitalized patients or those living in nursing homes. This case report describes a patient with a right facial carbuncle complicated by co-infection with COVID-19 and drug toxicity. PATIENT CONCERNS: A 73-year-old Malaysian Chinese woman with a history of chronic hypertension, diabetes mellitus, dyslipidemia, and cerebrovascular accident presented to the Emergency Department with dehydration, acute kidney injury, and a right temple carbuncle with pre-septal involvement. DIAGNOSES: A definitive diagnosis of the infection was made through a swab of the carbuncle pus, which was sent for microorganism culture and sensitivity testing.
interventionsAt the Emergency Department, the patient was initially treated with intravenous (IV) ampicillin-sulbactam (Unasyn) 1.5 g 3 times daily. Despite this, the right facial swelling increased in size. On the fourth day of admission, IV metronidazole 500 mg 3 times daily was added, resulting in a notable reduction in swelling. Incision and drainage of the carbuncle were performed under local anesthesia, followed by daily wound dressings with diluted povidone-iodine solution. Based on blood culture and sensitivity results confirming MRSA infection, IV Unasyn and metronidazole were replaced with vancomycin 2 g initially, then adjusted to 1 g twice daily. However, vancomycin was discontinued after 3 days due to hyperkalemia, and oral Bactrim was initiated. The wound was dressed with hydrogen peroxide and povidone-iodine for their synergistic effects. The infection was effectively managed, leading to progressive wound healing. OUTCOMES: Complete healing of the MRSA-infected skin and soft tissue wound by secondary intention was achieved by the 7th week posthospital admission. LESSONS: Localized MRSA infections of the face can be effectively managed with a combination of medical and surgical interventions. The defect in the temple area healed by secondary intention, resulting in an acceptable cosmetic outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.